Klaria Pharma Holding AB (STU:6FN) Days Sales Outstanding : 169.74 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB Days Sales Outstanding?

Klaria Pharma Holding AB's average Accounts Receivable for the three months ended in Dec. 2024 was €0.17 Mil. Klaria Pharma Holding AB's Revenue for the three months ended in Dec. 2024 was €0.09 Mil. Hence, Klaria Pharma Holding AB's Days Sales Outstanding for the three months ended in Dec. 2024 was 169.74.

The historical rank and industry rank for Klaria Pharma Holding AB's Days Sales Outstanding or its related term are showing as below:

STU:6FN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.16 Med: 98.33 Max: 516.89
Current: 516.89

During the past 11 years, Klaria Pharma Holding AB's highest Days Sales Outstanding was 516.89. The lowest was 9.16. And the median was 98.33.

STU:6FN's Days Sales Outstanding is ranked worse than
98.44% of 960 companies
in the Drug Manufacturers industry
Industry Median: 72.085 vs STU:6FN: 516.89

Klaria Pharma Holding AB's Days Sales Outstanding increased from Dec. 2023 (101.00) to Dec. 2024 (169.74).

Klaria Pharma Holding AB Days Sales Outstanding Historical Data

The historical data trend for Klaria Pharma Holding AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klaria Pharma Holding AB Days Sales Outstanding Chart

Klaria Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

137.39

60.11

228.36

Klaria Pharma Holding AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															101.00	-	-	-	169.74

Competitive Comparison of Klaria Pharma Holding AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klaria Pharma Holding AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Klaria Pharma Holding AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Klaria Pharma Holding AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.048	+	0.196)	/	2 )	/	0.195	*	365
=	0.122					/	0.195	*	365
=	228.36

Klaria Pharma Holding AB's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.15	+	0.196)	/	2 )	/	0.093	*	365 / 4
=	0.173					/	0.093	*	365 / 4
=	169.74

Klaria Pharma Holding AB (STU:6FN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Klaria Pharma Holding AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Klaria Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

KLAR:Sweden

Address

Virdings Alle 2, Uppsala, SWE, 754 50

Website

https://www.klaria.com

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines